Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.98 USD | +1.54% | +2.59% | +7.03% |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Capitalization 1 | 139.3 | 60.88 | 59.43 | 79.28 | - | - |
Enterprise Value (EV) 1 | 139.3 | 60.88 | 59.43 | 79.28 | 79.28 | 79.28 |
P/E ratio | -2.02 x | -2.31 x | -2.15 x | -2.03 x | -1.42 x | -1.09 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | - | - | - | - | - | - |
EV / Revenue | - | - | - | - | - | - |
EV / EBITDA | - | - | - | - | - | - |
EV / FCF | - | -1.4 x | - | -1.4 x | -1.17 x | -0.8 x |
FCF Yield | - | -71.7% | - | -71.3% | -85.8% | -125% |
Price to Book | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 22,036 | 28,989 | 32,122 | 40,039 | - | - |
Reference price 2 | 6.320 | 2.100 | 1.850 | 1.980 | 1.980 | 1.980 |
Announcement Date | 3/30/22 | 3/23/23 | 3/26/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - |
EBITDA | - | - | - | - | - | - | - |
EBIT 1 | - | -28.6 | -43.55 | -50.72 | -64.78 | -82.63 | -109.3 |
Operating Margin | - | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | - | -11.72 | -21.4 | -25.79 | -39.18 | -64.42 | -91.83 |
Net income 1 | -12.07 | -16.25 | -21.4 | -25.79 | -39.18 | -64.42 | -91.83 |
Net margin | - | - | - | - | - | - | - |
EPS 2 | -7.350 | -3.130 | -0.9100 | -0.8600 | -0.9750 | -1.397 | -1.820 |
Free Cash Flow 1 | - | - | -43.64 | - | -56.5 | -68 | -99.2 |
FCF margin | - | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - |
Announcement Date | 5/7/21 | 3/30/22 | 3/23/23 | 3/26/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBIT 1 | -5.223 | -11.81 | -9.413 | -12.21 | -12.62 | -9.3 | -8.973 | -11.82 | -14.74 | -15.19 | -15.66 | -16.27 | -16.91 | -17.57 |
Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | - | -7.339 | -3.713 | -5.877 | -6.625 | -5.182 | -6.172 | -4.726 | -6.749 | -8.141 | -8.521 | -8.127 | -9.317 | -10.39 |
Net income 1 | - | -7.545 | -3.838 | -5.752 | -6.625 | -5.182 | -6.172 | -4.726 | -6.749 | -8.141 | -8.521 | -8.127 | -9.317 | -10.39 |
Net margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EPS 2 | - | -0.4000 | -0.1700 | -0.2500 | -0.2900 | -0.2000 | -0.2100 | -0.1600 | -0.2200 | -0.2700 | -0.2467 | -0.2233 | -0.2033 | -0.1933 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 11/17/21 | 3/30/22 | 5/11/22 | 8/9/22 | 11/14/22 | 3/23/23 | 5/4/23 | 8/8/23 | 11/2/23 | 3/26/24 | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
Free Cash Flow 1 | - | - | -43.6 | - | -56.5 | -68 | -99.2 |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - |
Capex 1 | - | 0.03 | 0.17 | - | - | - | - |
Capex / Sales | - | - | - | - | - | - | - |
Announcement Date | 5/7/21 | 3/30/22 | 3/23/23 | 3/26/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.03% | 79.28M | |
-1.65% | 103B | |
+6.75% | 101B | |
+5.71% | 23.07B | |
-12.60% | 22.23B | |
-9.70% | 18.05B | |
-39.98% | 17.18B | |
-10.17% | 16.94B | |
+6.12% | 14.07B | |
+35.47% | 12.35B |
- Stock Market
- Equities
- CGTX Stock
- Financials Cognition Therapeutics, Inc.